Prevalence and determinants of the metabolic syndrome among subjects with advanced nondiabetes-related chronic kidney disease in Gran Canaria, Spain

被引:5
作者
Boronat, Mauro [1 ,2 ]
Bosch, Elvira [3 ]
Lorenzo, Dionisio [4 ]
Quevedo, Virginia [5 ]
Lopez-Rios, Laura [1 ]
Riano, Marta [6 ]
Garcia-Delgado, Yaiza [1 ]
Garcia-Canton, Cesar [3 ]
机构
[1] Hosp Univ Insular, Sect Endocrinol & Nutr, Avda Maritima del Sur S-N, Las Palmas Gran Canaria 35016, Spain
[2] Univ Las Palmas Gran Canaria, Dept Med & Surg Sci, Las Palmas Gran Canaria, Las Palmas, Spain
[3] Hosp Univ Insular, Serv Nephrol, Las Palmas Gran Canaria, Spain
[4] Univ Fernando Pessoa Canarias, Fac Hlth Sci, Las Palmas Gran Canaria, Spain
[5] Ctr Med Aconquija, San Miguel De Tucuman, Argentina
[6] Hosp Univ Insular, Serv Clin Biochem, Las Palmas Gran Canaria, Spain
关键词
Metabolic syndrome X; renal insufficiency; chronic kidney failure; chronic prevalence; Spain; INSULIN-RESISTANCE; RENAL-DISEASE; RISK; CKD; METAANALYSIS; PROPOSALS; PREDICTOR; OBESITY; COHORT; ADULTS;
D O I
10.3109/0886022X.2015.1117904
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The relationship between the metabolic syndrome and mild chronic kidney disease (CKD) has been extensively studied. This study was aimed to estimate the prevalence and factors associated with the metabolic syndrome among subjects with advanced stages of nondiabetes-related CKD. Methods Study population was composed of incident patients with advanced CKD not related to diabetes in a tertiary hospital from Gran Canaria (Spain) since February 2011 to December 2014. Participants fulfilled a survey questionnaire and underwent physical examination and biochemical evaluation. Results The sample was composed of 167 subjects (mean age 63.9 +/- 13.7 years; estimated glomerular filtration rate 21.9 +/- 6.6 mL/min/1.73 m(2)). The prevalence of the metabolic syndrome was 68.9% (65.2% in men and 73.3% in women). Highest rates were observed in groups with chronic interstitial nephropathy (80%), CKD of uncertain etiology (76.7%) and CKD related to vascular causes (76.2%). Subjects with metabolic syndrome were older, had higher values of C-reactive protein and more often reported to have first-degree relatives with diabetes and to be physically inactive. In multivariate analyses, age (OR: 1.034 [CI 95%: 1.004-1.065]; p = 0.024) and family history of diabetes (OR: 2.550 [1.159-5.608]; p = 0.020) were independently associated with the metabolic syndrome. Conclusions The prevalence of the metabolic syndrome among subjects with advanced nondiabetes-related CKD is high, and greater than that observed in general Canarian population of similar age groups. Age and family history of diabetes are the two factors more strongly associated with the metabolic syndrome in this population.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 39 条
[31]   Prevalence and metabolic risk factors of chronic kidney disease among a Mexican adult population: a cross-sectional study in primary healthcare medical units [J].
Paredes, Alfonso R. Alvarez ;
Garcia, Anel Gomez ;
Paredes, Martha Angelica Alvarez ;
Velazquez, Nely ;
Bolanos, Diana Cindy Ojeda ;
Sandoval, Miriam Sarai Padilla ;
Gallardo, Juan M. ;
Cortes, Gerardo Munoz ;
Granados, Seydhel Cristina Reyes ;
Moran, Mario Felipe Rodriguez ;
Tripp, Joaquin ;
Pineda, Arturo Lopez ;
Aguilar, Cleto Alvarez .
PEERJ, 2024, 12
[32]   Higher oxidative balance score is linearly associated with reduced prevalence of chronic kidney disease in individuals with metabolic syndrome: evidence from NHANES 1999-2018 [J].
Zhu, Linying ;
Ruan, Xiaoyi ;
Wang, Jianqi ;
Yan, Yongxing ;
Tang, Chunyuan ;
Xu, Yuanwen .
FRONTIERS IN NUTRITION, 2024, 11
[33]   Association between metabolic syndrome and incident chronic kidney disease among Chinese: A nation-wide cohort study and updated meta-analysis [J].
Wu, Nianwei ;
Qin, Yao ;
Chen, Sen ;
Yu, Chuan ;
Xu, Ying ;
Zhao, Jian ;
Yang, Xue ;
Li, Ningxiu ;
Pan, Xiong-Fei .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (07)
[34]   High prevalence of chronic kidney disease in La Reunion island and its association with the metabolic syndrome in the non-diabetic population: La Reunion Diabetes (REDIA) Study [J].
Stengel, B. ;
Jaussent, I. ;
Guiserix, J. ;
Bourgeon, B. ;
Papoz, L. ;
Favier, F. .
DIABETES & METABOLISM, 2007, 33 (06) :444-452
[35]   Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China [J].
Li, Hangtian ;
Wang, Qian ;
Ke, Jianghua ;
Lin, Wenwen ;
Luo, Yayong ;
Yao, Jin ;
Zhang, Weiguang ;
Zhang, Li ;
Duan, Shuwei ;
Dong, Zheyi ;
Chen, Xiangmei .
NUTRIENTS, 2022, 14 (07)
[36]   Effect of poor glycemic control on the prevalence and determinants of anemia and chronic kidney disease among type 2 diabetes mellitus patients in Jordan: An observational cross-sectional study [J].
Al-Dwairi, Ahmed ;
Al-Shboul, Othman ;
Al-U'datt, Doa'a G. F. ;
Saadeh, Rami ;
Alqudah, Mohammad ;
Khassawneh, Adi ;
Alfaqih, Mahmoud ;
Albtoush, Alhakam ;
Hweidi, Aysam ;
Alnemer, Abdulaziz .
PLOS ONE, 2024, 19 (11)
[37]   Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study [J].
Ma, Aixia ;
Liu, Fuqiang ;
Wang, Chuan ;
Liang, Kai ;
Yan, Fei ;
Hou, Xinguo ;
Liu, Jinbo ;
Chen, Li .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (12) :2239-2244
[38]   Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study [J].
Aixia Ma ;
Fuqiang Liu ;
Chuan Wang ;
Kai Liang ;
Fei Yan ;
Xinguo Hou ;
Jinbo Liu ;
Li Chen .
International Urology and Nephrology, 2018, 50 :2239-2244
[39]   Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease [J].
Kountouras, Jannis ;
Polyzos, Stergios A. ;
Kazakos, Evangelos ;
Papanikolaou, Ioannis S. ;
Liatsos, Christos ;
Vardaka, Elisabeth ;
Tzilves, Dimitrios ;
Vlachaki, Efthimia .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (04) :540-541